High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone.
| Image |  |
|---|---|
| Description | scientific article published on January 2008 |
| Author/s |
author: Fenghuang Zhan Barbara Bryant |
| Publication date | January 1, 2008 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |